Mutations in genes encoding ion channels, transporters, exchangers, and pumps in human tissues have been increasingly reported to cause hypokalemia. Assessment of history and blood pressure as well as the K + excretion rate and blood acid-base status can help differentiate between acquired and inherited causes of hypokalemia. Familial periodic paralysis, Andersen's syndrome, congenital chloride-losing diarrhea, and cystic fibrosis are genetic causes of hypokalemia with low urine K + excretion. With respect to a high rate of K + excretion associated with faster Na + disorders (mineralocorticoid excess states), glucoricoid-remediable aldosteronism and congenital adrenal hyperplasia due to either 11β-hydroxylase and 17α-hydroxylase deficiencies in the adrenal gland, and Liddle's syndrome and apparent mineralocorticoid excess in the kidney form the genetic causes. Among slow Cl¯ disorders (normal blood pressure, low extracellular fluid volume), Bartter's and Gitelman's syndrome are most common with hypochloremic metabolic alkalosis. Renal tubular acidosis caused by mutations in the basolateral Na + /HCO 3¯ cotransporter (NBC1) in the proximal tubules, apical H + -ATPase pump, and basolateral Cl¯/HCO 3¯ exchanger (anion exchanger 1, AE1) in the distal tubules and carbonic anhydroase II in both are genetic causes with hyperchloremic metabolic acidosis. Further work on genetic causes of hypokalemia will not only provide a much better understanding of the underlying mechanisms, but also set the stage for development of novel therapies in the future.
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Tom Chau, M.D. . Prompt diagnosis with appropriate management of hypokalemia avoids
With the unprecedented progress in molecular and genetic analysis, many previously confusing phenotypic features of the inherited disorders can now be understood 2) .
Of note, although hypokalemia in these genetic disorders may be the foremost finding, one should understand that hypokalemia per se is not a specific disease but an associated finding in a large number of different diseases 3) .
An accurate diagnosis will help determine the molecular defect if the basis for hypokalemia is a genetic disorder. In this paper, our approach to hypokalemia is introduced and the genetic causes of hypokalemia are discussed to provide some insights in the field. . Derangements in either the internal balance (e.g. K + shift) or external balance (e.g. K + wasting) can result in hypokalemia.
Regulation of K + between ICF and ECF 1) Driving force
The force driving K + shift into cells is the more negative voltage in cells. This is created by the Na . Closure or opening may not only alter the membrane potential, but also acutely affect the plasma K + concentration. . .
1) The flow rate in the CCD
The flow rate in the CCD is directly proportional to the rate of excretion of osmoles and can be expressed as the urine osmole excretion rate divided by plasma osmolality (unrine osmolality × volume/plasma oslmolality) because urine osmolality in the terminal CCD is equal to the plasma osmolality when anti-diuretic hormone (ADH) is present 8) . . In contrast, conditions of intracellular shift usually exhibit relatively normal acidbase balance. Accordingly, the simultaneous assessment of blood acid-base state is also very crucial in patients with hypokalemia. Therefore, the etiology of hypokalemia can simply be divided into two groups: those with a low K + excretion rate and those with a high K + excretion rate.
1. Disorders with a low urine K + excretion rate . The Na + channel α-subunit shares primary and secondary structure with the Ca 2+ channel α-subunit including segments spanning the membrane (S1-S6). The . Why mutations in segment S4 of CACNA1S and SCN4A cause episodic hypokalemia remains unclear.
(2) Andersen-Tawil syndrome
It is an autosmal-dominant channelopathy resulting in episodic attacks of muscle weakness (mainly acute hypokalemia, but can be normo-or hyperkalemia), cardiac arrhythmia (ventricular arrhythmias and QT prolongation) and distinctive physical features 19) . Mutations in the gene (KCNJ2) encoding a pore-forming subunit of the inward rectifier K + channel protein, Kir2.1, which is expressed in skeletal muscles and heart, lead to this syndrome 19) . .
2) Genetic hypokalemia where the defect is in the intes tinal tract
Congenital chloride-losing diarrhea (CLD) is a rare . . In this setting, measurement of plasma renin activity, aldosterone and cortisol concentration help to narrow the differential diagnosis of fast Na + disorders (Fig. 2) . Plasma renin The mineralocorticoid receptor (MR), the major regulator of ENaC activity, is normally activated by aldosterone.
Genetic mutations causing abnormalities in aldosterone secretion or production of other steroids that activate the MR will lead to hypertension and hypokalemia 24) .
i. Glucorticoid-remediable aldosteronism GRA is an autosomal dominant form of hypertension caused by a chimeric gene duplication arising from unequal crossing over between two closely related genes involved in adrenal steroid biosynthesis 25) . These two genes iii. Liddle's syndrome It is characterized by autosomal dominant transmission of early onset hypertension associated with hypokalemia, metabolic alkalosis, suppressed plasma renin activity, and extremely low plasma aldosterone levels 28) . This disease is caused by mutations in either the β or the γ subunit of ENaC that delete or alter their cytoplasmic C termini. iv. Apparent mineralocorticoid excess (AME) AME is a rare but potentially fatal autosomal recessive form of hypertension and hypokalemic metabolic alkalosis associated with hyporeninemia and hypoaldosteronemia and an abnormal ratio of urinary metabolites of cortisol with a high tetrahydrocortisol:tet rahydrocortisone (THF:THE) ratio 29) . AME is caused by mutations in the gene (HSD11B2) encoding renal-specific 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2).
11β-HSD2 is responsible for converting cortisol to cortisone in the principal cells of distal tubules and crucial for protecting the MR from being occupied by cortisol.
The hallmark features in AME resemble those in licorice ingestion because licorice contains glycyrrhetinic acid, which inhibits 11β-HSD2 30) . PCT, proximal convoluted tubule; LOH, loop of Henle; DCT, distal convoluted tubule; CD, collecting duct; AD, autosomal dominant; AR, autosomal r ecessive; RBC, red blood cell; GRA, glucocorticoid-remediable aldosteronism; FPP, familial periodic paralysis; CLD, congenital chloride-losing diarrhea; CF, cystic fibrosis; CAH, congenital adrenal hyperplasia; AME, apparent mineralocorticoid excess; BS, Bartter's syndrome; GS, Gitelman's syndrome; pRTA, proximal renal tubular acidosis; dRTA, distal renal tubular acidosis; MES, mineralocorticoid excess state; SeSAME, seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance. . Fig. 3 ). Recently, a complex syndrome consisting of a combination of epilepsy, ataxia, sensorineural deafness and renal tubulopathy featuring laboratory findings of GS (EAST or SeSAME syndrome)
(2) Slow Cl¯ disorders
has been described, due to inactivating mutations in the gene encoding Kir4.1, which is also highly expressed in the basolateral membrane of the DCT 37, 38) . Loss of Kir4.1 function may reduce Na . . Because ATP6V1B1 is also expressed in endolymphatic sac epithelia, mutations in ATP6V1B1 cause distal RTA with sensorineural hearing loss, whereas, distal RTA with preserved hearing is caused by mutations in ATP6V0A4. AE1 (SLC4A1) is also present in erythrocytes and inactivating mutation in AE1 causes distal RTA and possible anemia 44) . 45) . The bone thinning effect of the coexistent metabolic acidosis in CA II deficiency may protect the osteopetrotic bones from the excessive thickening generated by osteoclast dysfunction.
Therapeutic strategy in genetic hypokalemia
Genetically engineered mice are often used as animal models of human diseases and are vital tools in investigating molecular pathogenesis of disease and developing and testing novel therapies. It is worthy to emphasize that knock-out mice typically represent null mutations and could be used to study only the effects of the loss of a gene, not a specific mutation 46) . Knockin strategies, where homologous recombination in embryonic stem (ES) cells is used to replace the endogenous gene with a mutant variant without any other disruption of the gene, can be used to address the effects of specific sequence changes on gene and protein function 47) . Therefore, knockin mice accurately represent human diseases caused by specific mutations, such as missense, nonsense, or deletion mutations. More importantly, mutation-specific approaches according to the different classes of mutations are currently under investigation to provide a new alternative therapy in genetic disorders. We believe that the application of these diseases-causing knock-in mice may address more specific questions regarding the pathogenesis and new directions in rescue therapies; for instance, rational application of aminoglycosides or premature termination codon (PTC) 124 for nonsense mutations and pharmacologic chaperones for missense mutations 48) .
Conclusion
Apart from a detailed history and careful physical examination, the measurement of urine K + excretion rate by spot and/or 24 hour urine, and assessment of blood acidbase status helps discriminate the causes of hypokalemia.
Once the clinical diagnosis suggests a likely molecular basis for the disorder, genetic analysis may prove the diagnosis.
Genetic causes of hypokalemia are shown in Table 1 .
Creation and investigation of disease-causing knockin mice as a model of genetic hypokalemia will not only provide a much better understanding of the underlying mechanisms; but also set the stage for the development of novel therapies in the future.
